Drug Shortage Report for MYLAN-CELECOXIB

Last updated on 2018-07-05 History
Report ID 140
Drug Identification Number 02399881
Brand name MYLAN-CELECOXIB
Common or Proper name Celecoxib
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CELECOXIB
Strength(s) 200MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BT
ATC code M01AH
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-07-03
Estimated end date Unknown
Actual end date 2018-07-03
Shortage status Resolved
Updated date 2018-07-05
Company comments Discontinued in ID 44830
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2018-07-05 French Compare
v15 2018-07-05 English Compare
v14 2018-07-04 English Compare
v13 2018-07-03 French Compare
v12 2018-07-03 English Compare
v11 2018-07-03 English Compare
v10 2018-04-03 French Compare
v9 2018-04-03 English Compare
v8 2017-04-25 French Compare
v7 2017-04-25 English Compare
v6 2017-04-13 French Compare
v5 2017-04-13 English Compare
v4 2017-03-29 French Compare
v3 2017-03-29 English Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare

Showing 1 to 16 of 16